Terri B. Sebree
2016
In 2016, Terri B. Sebree earned a total compensation of $681.8K as President at Zynerba Pharmaceuticals, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $256,470 |
|---|---|
| Salary | $412,000 |
| Other | $13,297 |
| Total | $681,767 |
Sebree received $412K in salary, accounting for 60% of the total pay in 2016.
Sebree also received $256.5K in non-equity incentive plan and $13.3K in other compensation.
Rankings
In 2016, Terri B. Sebree's compensation ranked 10,000th out of 14,075 executives tracked by ExecPay. In other words, Sebree earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,000 out of 14,075 | 29th |
Division Manufacturing | 3,858 out of 5,489 | 30th |
Major group Chemicals And Allied Products | 1,356 out of 1,895 | 28th |
Industry group Drugs | 1,083 out of 1,538 | 30th |
Industry Pharmaceutical Preparations | 850 out of 1,176 | 28th |
Source: SEC filing on April 23, 2018.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2016.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019